Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MTEX
MTEX logo

MTEX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
5.420
Open
5.220
VWAP
5.33
Vol
14.29K
Mkt Cap
10.46M
Low
5.140
Amount
76.14K
EV/EBITDA(TTM)
5.58
Total Shares
1.93M
EV
7.18M
EV/OCF(TTM)
--
P/S(TTM)
0.10
Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.
Show More

Events Timeline

(ET)
2026-04-07
16:00:00
Mannatech Trading Halted Due to Volatility
select
2024-11-26 (ET)
2024-11-26
15:30:47
Mannatech names Robert Toth vice chairman of the board
select

News

seekingalpha
5.0
06-08seekingalpha
Mannatech Appoints New CFO Yasir Haider
  • Executive Appointment: Mannatech has appointed Yasir Haider as Chief Financial Officer, effective June 3, 2026, marking a significant shift in the company's financial leadership aimed at enhancing financial management efficiency.
  • Interim Management: Haider was named Interim CFO on March 20, 2026, demonstrating the company's flexibility and adaptability during the search for a long-term financial leader, ensuring continuity in financial operations.
  • Successor Transition: Haider succeeds former CFO James Clavijo, who contributed to the implementation of the company's financial strategy during his tenure, and this leadership change may impact the company's financial direction and strategy.
  • Extensive Experience: Prior to joining Mannatech, Haider held senior finance leadership positions, including CFO and financial controller roles, providing a solid foundation for his new role and aiding in driving the company's financial health and growth.
seekingalpha
9.5
05-14seekingalpha
Mannatech Q1 Financial Highlights
  • Earnings Per Share: Mannatech reported a GAAP EPS of $0.49 for Q1, indicating stable profitability; however, the lack of growth compared to the previous year highlights the pressure the company faces in maintaining earnings.
  • Revenue Decline: The company’s revenue of $24.92 million reflects a 6.2% year-over-year decrease, signaling weak market demand and intensified competition, which could impact future market share and growth potential.
  • Financial Transparency: Mannatech has provided detailed financial information to enhance investor confidence, aiming to attract more attention despite current underperformance through transparent reporting.
  • Market Challenges: With declining revenue and profitability pressures, Mannatech may need to reassess its market strategy to address competition and changing consumer demands in the industry.
seekingalpha
9.5
04-20seekingalpha
Mannatech Reports Q4 Financial Results with Significant Losses
  • Financial Loss: Mannatech reported a Q4 GAAP EPS of -$5.94, indicating significant challenges in profitability and reflecting ongoing financial pressure on the company.
  • Revenue Decline: The company's Q4 revenue of $26.6 million represents an 8.3% year-over-year decrease, suggesting weakened market demand that could impact future business growth and investor confidence.
  • Deteriorating Cash Position: As of December 31, 2025, Mannatech's cash and cash equivalents fell to $6.2 million from $11.4 million as of December 31, 2024, highlighting increased liquidity risks that may limit operational flexibility.
  • Uncertain Future Outlook: Given the poor financial performance, Mannatech faces pressure to reassess its business strategy, and investors should monitor how the company addresses current financial challenges to restore growth.
Newsfilter
9.5
04-17Newsfilter
Mannatech Reports $15.2 Million Net Loss for 2025 Fiscal Year
  • Sales Decline: Mannatech reported fourth-quarter net sales of $26.6 million for 2025, an 8.2% decrease compared to the previous year, primarily due to the implementation of a new ordering system in North America that weakened sales momentum, indicating significant market pressure.
  • Gross Margin Erosion: The gross margin for 2025 fell to 74.9% from 77.6% in 2024, largely driven by supply chain challenges and rising product costs, highlighting the company's difficulties in maintaining cost control amid increasing expenses.
  • Increased Operating Loss: The company experienced an operating loss of $0.4 million in 2025, a stark contrast to the $1.4 million operating income in 2024, underscoring the challenges in operational efficiency in a deteriorating revenue environment.
  • Tightening Cash Flow: As of December 31, 2025, Mannatech's cash and cash equivalents decreased to $6.2 million from $11.4 million in 2024, indicating heightened liquidity risks and the need for improved financial management to navigate future uncertainties.
moomoo
9.5
04-17moomoo
MANNATECH ANNOUNCES FINANCIAL RESULTS FOR Q4 AND FULL YEAR 2025
  • Financial Results Overview: The financial results for the fourth quarter and year-end of 2025 have been reported, highlighting key performance metrics and overall financial health.

  • Revenue and Profit Trends: The report indicates trends in revenue and profit, showcasing growth or decline compared to previous periods.

  • Operational Highlights: Key operational achievements and challenges faced during the year are summarized, providing insight into the company's performance.

  • Future Outlook: The report concludes with a forward-looking statement, outlining expectations and strategic plans for the upcoming year.

Newsfilter
9.5
04-01Newsfilter
Mannatech Files for Extension on Annual Report Submission
  • Annual Report Delay: Mannatech has filed a Form 12b-25 with the SEC to delay the submission of its 2025 fiscal year annual report, originally due on March 31, 2026, now extended by 15 days to April 15, 2026.
  • Compliance Measures: By submitting Form 12b-25, Mannatech ensures adherence to SEC regulations, although this delay may impact investor confidence, the company is committed to filing the report promptly to maintain transparency.
  • Market Impact: This delay could negatively affect Mannatech's stock price, particularly as investor scrutiny on the company's financial health intensifies, potentially lowering market expectations for future growth.
  • Business Outlook: Operating in over 25 markets globally, Mannatech faces challenges from COVID-19 and increased competition, yet remains focused on driving growth through science-backed nutritional products, with upcoming financial reports serving as critical indicators of strategic execution.

Valuation Metrics

The current forward P/E ratio for Mannatech Inc (MTEX.O) is 9.57, compared to its 5-year average forward P/E of 0.87. For a more detailed relative valuation and DCF analysis to assess Mannatech Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.87
Current PE
9.57
Overvalued PE
3.45
Undervalued PE
-1.71

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

u.s.stocks that are surging
Intellectia · 30 candidates
Region: USPrice Change Pct: >= $8.00Relative Vol: >= 2New High Low: 5_High, 20_HighList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Week Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
MTEX logo
MTEX
Mannatech Inc
8.43M
SKIN logo
SKIN
Skinhealth Systems Inc
89.13M
VICR logo
VICR
Vicor Corp
12.22B
LFVN logo
LFVN
LifeVantage Corp
70.77M
VATE logo
VATE
Innovate Corp
178.71M
CBAT logo
CBAT
CBAK Energy Technology Inc
66.48M
btdr, wulf, corz. irm,eqix, dlr,apld and mrvl
Intellectia · 1677 candidates
Region: USPrice: >= $-100.00Rsi Category: moderate, overboughtRelative Vol: >= 1Moving Average Relationship: PriceAboveMA20, PriceAboveMA200, PriceCrossAboveMA20, PriceCrossAboveMA200Ema 20: >= -100Ema 60: >= -100Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
VCIG logo
VCIG
VCI Global Ltd
4.90M
MNTS logo
MNTS
Momentus Inc
73.74M
AIMD logo
AIMD
Ainos Inc
13.04M
PHGE logo
PHGE
BiomX Inc
8.28M
CPSH logo
CPSH
CPS Technologies Corp
108.04M
CODX logo
CODX
Co-Diagnostics Inc
26.62M
trade analysis of top five gap upstocks
Intellectia · 61 candidates
Relative Vol: >= 1.50Gap Pattern: GapUpMoving Average Relationship: PriceAboveMA5, PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
AEHL logo
AEHL
Antelope Enterprise Holdings Ltd
6.19M
RXT logo
RXT
Rackspace Technology Inc
1.37B
WEST logo
WEST
Westrock Coffee Co
804.85M
FLNC logo
FLNC
Fluence Energy Inc
4.45B
VRAX logo
VRAX
Virax Biolabs Group Ltd
1.27M
MRAM logo
MRAM
Everspin Technologies Inc
632.85M
what’s the best three to buy right now
Intellectia · 1718 candidates
Region: USPrice Change Pct: >= $0.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5, PriceAboveMA20
Ticker
Name
Market Cap$
top bottom
MTEX logo
MTEX
Mannatech Inc
9.01M
AEHL logo
AEHL
Antelope Enterprise Holdings Ltd
2.63M
CODX logo
CODX
Co-Diagnostics Inc
6.95M
BCDA logo
BCDA
BioCardia Inc
11.93M
CTM logo
CTM
Castellum Inc
62.12M
TC logo
TC
Token Cat Ltd
18.98M

Whales Holding MTEX

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Mannatech Inc (MTEX) stock price today?

The current price of MTEX is 5.42 USD — it has increased 1.12

What is Mannatech Inc (MTEX)'s business?

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.

What is the price predicton of MTEX Stock?

Wall Street analysts forecast MTEX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for MTEX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Mannatech Inc (MTEX)'s revenue for the last quarter?

Mannatech Inc revenue for the last quarter amounts to 24.92M USD, decreased -6.20

What is Mannatech Inc (MTEX)'s earnings per share (EPS) for the last quarter?

Mannatech Inc. EPS for the last quarter amounts to 0.49 USD, decreased -161.25

How many employees does Mannatech Inc (MTEX). have?

Mannatech Inc (MTEX) has 170 emplpoyees as of June 21 2026.

What is Mannatech Inc (MTEX) market cap?

Today MTEX has the market capitalization of 10.46M USD.